Stuart Diamond insider trades: Medicis Pharmaceutical (MRX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Stuart reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 20, 2012 | MRX | ↓ Sell | 17,500 | $32.76 | $573K | Direct | Aug 22, 2012 (2d) |
| May 19, 2008 | MRX | ↑ Buy | 3,850 | $22.43 | $86K | Direct | May 20, 2008 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other MRX insiders
Open-market trades in the last 12 months
About Stuart Diamond's insider trades
Stuart Diamond is an insider at Medicis Pharmaceutical (MRX). Since May 19, 2008, Stuart has reported 1 open-market purchase worth $86K and 1 sale worth $573K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (16 filings), other transactions (2 filings), shares returned to the company (2 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MRX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.